Zymosan inflammation: a new method suitable for evaluating new antiinflammatory drugs.
Gadó
K
K
EGIS Pharmaceuticals, Budapest, Hungary.
Gigler
G
G
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002351:Carrageenan; D004195:Disease Models, Animal; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D007249:Inflammation / Q000139:chemically induced* / Q000188:drug therapy; D051381:Rats; D011919:Rats, Inbred Strains; D015054:Zymosan
D000893:Anti-Inflammatory Agents; D002351:Carrageenan; D015054:Zymosan